Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

Title:	Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
Authors:	Manisty, C Otter, AD Treibel, TA McKnight, A Altmann, DM Brooks, T Noursadeghi, M Boyton, RJ Semper, A Moon, JC
Item Type:	Journal Article
Issue Date:	20-Mar-2021
Date of Acceptance:	1-Feb-2021
URI:	http://hdl.handle.net/10044/1/88153
DOI:	10.1016/S0140-6736(21)00501-8
ISSN:	0140-6736
Publisher:	Elsevier
Start Page:	1057
End Page:	1058
Journal / Book Title:	The Lancet
Volume:	397
Issue:	10279
Copyright Statement:	© 2021 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Sponsor/Funder:	Medical Research Council (MRC)
Funder's Grant Number:	MR/V036939/1
Keywords:	Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine Antibodies, Viral Asymptomatic Infections COVID-19 COVID-19 Vaccines Case-Control Studies Humans Immunization Schedule Immunogenicity, Vaccine SARS-CoV-2 Humans Antibodies, Viral Immunization Schedule Case-Control Studies Asymptomatic Infections Immunogenicity, Vaccine COVID-19 SARS-CoV-2 COVID-19 Vaccines Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine 11 Medical and Health Sciences General & Internal Medicine
Publication Status:	Published
Online Publication Date:	2021-02-25
Appears in Collections:	Department of Immunology and Inflammation Department of Infectious Diseases Faculty of Medicine Imperial College London COVID-19

This item is licensed under a Creative Commons License